🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Blessed to have won the Chinese American Hematologist & Oncologist Network (Chinese American Hematologist & Oncologist Network) Young Investigator Award & to be honored w/ all the other great young investigators at the CAHON Winter Symposium last night! #ASH24 #ASHKudos #ASHTrainee

Valemetostat, an EZH1/2 inhibitor approved in Japan for Adult T cell lymphoma/leukemia, has an ORR of 46% in R/R disease. Sadly Daiichi Sankyo US has NO valemetostat compassionate use program in the US. None. #ASH24 maya srinivasan HTLV Aware HTLV.net @StefanBartaMD

We extend our heartfelt thanks to all the dedicated professionals who contributed to the success of the 2024 Winter Symposium! The CAHON Winter Symposium takes place annually alongside the American Society of Hematology (ASH) Annual Meeting. We look forward to seeing

Congratulations to our Young Investigator Award recipients, Drs. James Fan Wu (Medical College of Wisconsin), Yuan Yao (Mayo Clinic), Xia Wu (Tufts Medical Center), Cho Han Chiang (Mount Auburn Hospital/Harvard Medical School), Yumeng Zheng (University of South Florida/Moffitt

First time writing an event report! Thank you for this opportunity!! cahon.org/featured-news/…

Drs. Minnie and Mickey Mouse heard about the Clinical Breakthroughs and Challenges in Hematologic Malignancies conference and were eager to learn about the latest advances! #Heme25

On National Women Physicians Day, we celebrate the women at Moffitt who are transforming cancer care through advocacy, research and compassionate patient-centered care. From improving rare disease diagnoses to amplifying patient voices in research, they ensure every patient is

Thank you for interviewing me for the advocacy for patients with rare disease. advocating for those patients isn’t just about offering better treatments — it’s about ensuring that the most overlooked members of the health care system are seen, heard and cared for.

CAHON COF 2025 — 20th anniversary. 🎊🎊🎊 kicking off in the beautiful cherry blossom season in national harbor.

CAHON and JHO are hosting a new event in Chicago this month. Registration and more information can be found here: cahon.org/events/upcomin… #JHO #CAHON #ASCO25

We are fighting against rare cancers TOGETHER! I am so privileged to be Ancil’s doctor and also so proud for him, his family and friends, have done, not just for him but for others with rare blood cancers! Sign up to be a bone marrow donor today! wctv.tv/2025/05/03/tal…

Artificial Intelligence and Machine Learning Innovations to Improve Design and Representativeness in Oncology Clinical Trials | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.12… #ASCO25

Another validation on MRD — things interesting to me 1) for MRD- patients, any difference in metabolic MR or PR. 2) do early treatment for MRD disease translate into improved survival? Or we are just separate out chemo resistance disease regardless?

Very interesting! I also like how the vertical axis was changed to make the difference look bigger on purpose.

🎙️ Catch Voices in Lymphoma: Women Shaping Care 💥 Decoding T-Cell Lymphomas: Diagnosis & Treatment 💥 📅 Tuesday, Feb 25 | 7 PM EST 🔗 hubs.li/Q03nmr1G0 Two Trailblazing Oncologists. One Game-Changing Conversation. 🔬👩‍⚕️

Happening at #ASCO25: Moffitt’s Andrew Kuykendall, MD (Andrew Kuykendall MD), presents results from VERIFY, an exciting phase 3 trial evaluating rusfertide for better control of red blood cell counts in patients with polycythemia vera, a rare chronic leukemia. Tune into the plenary

Very inspiring talk. One of the best points is that as clinical researchers, we really should share with public why we are excited about what we do and how is it going to change cancer care in the future.

Don’t miss Andrew Kuykendall, MD, (Andrew Kuykendall MD) present results from VERIFY, a landmark phase 3 trial using rusfertide for polycythemia vera, a rare chronic leukemia. Tune into the ASCO plenary today! #MoffittASCO25

Kimberly is the best ❤️

A 19M has fever, HA, AMS after diving in a warm FL spring. CSF: ↑OP, PMNs, ↓glucose, neg Gram. Dx? A) Listeria B) Neisseria C) Naegleria D) Crypto E) HSV 💡 C. Naegleria fowleri —PAM meningitis from fresh water Learn high yield IM board from Dr. Lezama: a.co/d/70zfC4g